Atovaquone Oral Suspension
OCTO_088
Phase 1 small_molecule completed
Quick answer
Atovaquone Oral Suspension for Locally Advanced Non-Small Cell Lung Cancer is a Phase 1 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Locally Advanced Non-Small Cell Lung Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed